GEP-NET

Clinical trials for GEP-NET explained in plain language.

Never miss a new study

Get alerted when new GEP-NET trials appear

Sign up with your email to follow new studies for GEP-NET, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Terminated 1

New radioactive drug enters human testing for Hard-to-Treat tumors

Disease control Not yet recruiting

This is the first human study of an experimental radioactive drug called RYZ401 for people with advanced neuroendocrine tumors and other solid tumors that have a specific marker. The main goals are to find the safest and most effective dose, check for side effects, and see if the…

Matched conditions: GEP-NET

Phase: PHASE1 • Sponsor: RayzeBio, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

GEP-NET

Get alerted when new GEP-NET trials appear

New radioactive drug enters human testing for Hard-to-Treat tumors